Annual CFI
-$7.53 B
-$7.49 B-20124.47%
December 31, 2023
Summary
- As of February 7, 2025, BNTX annual cash flow from investing activities is -$7.53 billion, with the most recent change of -$7.49 billion (-20124.47%) on December 31, 2023.
- During the last 3 years, BNTX annual CFI has fallen by -$7.36 billion (-4452.95%).
- BNTX annual CFI is now -20124.47% below its all-time high of -$37.23 million, reached on December 31, 2022.
Performance
BNTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$214.99 M
+$23.18 M+9.73%
September 1, 2024
Summary
- As of February 7, 2025, BNTX quarterly cash flow from investing activities is -$214.99 million, with the most recent change of +$23.18 million (+9.73%) on September 1, 2024.
- Over the past year, BNTX quarterly CFI has increased by +$2.68 billion (+92.56%).
- BNTX quarterly CFI is now -166.66% below its all-time high of $322.50 million, reached on March 31, 2022.
Performance
BNTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$5.85 B
+$1.12 B+16.09%
September 1, 2024
Summary
- As of February 7, 2025, BNTX TTM cash flow from investing activities is -$5.85 billion, with the most recent change of +$1.12 billion (+16.09%) on September 1, 2024.
- Over the past year, BNTX TTM CFI has increased by +$1.68 billion (+22.33%).
- BNTX TTM CFI is now -89988.50% below its all-time high of $6.51 million, reached on September 30, 2022.
Performance
BNTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BNTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | +92.6% | +22.3% |
| 3 y3 years | -4452.9% | -166.7% | -1767.1% |
| 5 y5 years | -9495.1% | -829.2% | -8966.3% |
BNTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -166.7% | +92.6% | <-9999.0% | +36.7% |
| 5 y | 5-year | <-9999.0% | at low | -166.7% | +92.6% | <-9999.0% | +36.7% |
| alltime | all time | <-9999.0% | at low | -166.7% | +92.6% | <-9999.0% | +36.7% |
BioNTech SE Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$214.99 M(-9.7%) | -$5.85 B(-16.1%) |
| Jun 2024 | - | -$238.16 M(-90.5%) | -$6.97 B(-24.6%) |
| Mar 2024 | - | -$2.50 B(-13.4%) | -$9.24 B(+22.8%) |
| Dec 2023 | -$7.53 B(>+9900.0%) | -$2.89 B(+116.3%) | -$7.53 B(+56.8%) |
| Sep 2023 | - | -$1.34 B(-46.8%) | -$4.80 B(+34.8%) |
| Jun 2023 | - | -$2.51 B(+217.9%) | -$3.56 B(+209.8%) |
| Mar 2023 | - | -$789.85 M(+382.0%) | -$1.15 B(+2988.0%) |
| Dec 2022 | -$37.23 M(-94.4%) | -$163.85 M(+70.7%) | -$37.23 M(-672.3%) |
| Sep 2022 | - | -$95.99 M(-3.9%) | $6.51 M(-101.7%) |
| Jun 2022 | - | -$99.88 M(-131.0%) | -$377.16 M(+20.4%) |
| Mar 2022 | - | $322.50 M(-368.5%) | -$313.20 M(-53.2%) |
| Dec 2021 | -$669.80 M | -$120.12 M(-75.0%) | -$669.80 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$479.66 M(+1235.4%) | -$662.42 M(+218.2%) |
| Jun 2021 | - | -$35.92 M(+5.3%) | -$208.18 M(+13.7%) |
| Mar 2021 | - | -$34.10 M(-69.8%) | -$183.02 M(+10.7%) |
| Dec 2020 | -$165.37 M(+91.3%) | -$112.74 M(+343.5%) | -$165.37 M(+156.4%) |
| Sep 2020 | - | -$25.42 M(+136.3%) | -$64.50 M(+3.7%) |
| Jun 2020 | - | -$10.76 M(-34.6%) | -$62.21 M(-4.6%) |
| Mar 2020 | - | -$16.44 M(+38.5%) | -$65.19 M(-24.6%) |
| Dec 2019 | -$86.43 M(+10.1%) | -$11.88 M(-48.7%) | -$86.43 M(+15.9%) |
| Sep 2019 | - | -$23.14 M(+68.4%) | -$74.55 M(+45.0%) |
| Jun 2019 | - | -$13.74 M(-63.5%) | -$51.41 M(+36.5%) |
| Mar 2019 | - | -$37.68 M | -$37.68 M |
| Dec 2018 | -$78.47 M(+31.9%) | - | - |
| Dec 2017 | -$59.51 M | - | - |
FAQ
- What is BioNTech SE annual cash flow from investing activities?
- What is the all time high annual CFI for BioNTech SE?
- What is BioNTech SE annual CFI year-on-year change?
- What is BioNTech SE quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioNTech SE?
- What is BioNTech SE quarterly CFI year-on-year change?
- What is BioNTech SE TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioNTech SE?
- What is BioNTech SE TTM CFI year-on-year change?
What is BioNTech SE annual cash flow from investing activities?
The current annual CFI of BNTX is -$7.53 B
What is the all time high annual CFI for BioNTech SE?
BioNTech SE all-time high annual cash flow from investing activities is -$37.23 M
What is BioNTech SE annual CFI year-on-year change?
Over the past year, BNTX annual cash flow from investing activities has changed by -$7.49 B (-20124.47%)
What is BioNTech SE quarterly cash flow from investing activities?
The current quarterly CFI of BNTX is -$214.99 M
What is the all time high quarterly CFI for BioNTech SE?
BioNTech SE all-time high quarterly cash flow from investing activities is $322.50 M
What is BioNTech SE quarterly CFI year-on-year change?
Over the past year, BNTX quarterly cash flow from investing activities has changed by +$2.68 B (+92.56%)
What is BioNTech SE TTM cash flow from investing activities?
The current TTM CFI of BNTX is -$5.85 B
What is the all time high TTM CFI for BioNTech SE?
BioNTech SE all-time high TTM cash flow from investing activities is $6.51 M
What is BioNTech SE TTM CFI year-on-year change?
Over the past year, BNTX TTM cash flow from investing activities has changed by +$1.68 B (+22.33%)